Targeting the cardiovascular
(CV)-kidney-metabolic (CKM) axis may improve outcomes in patients
with type 2 diabetes (T2D) and chronic kidney disease (CKD) by
addressing interconnected metabolic, kidney, and CV risks.
Credit available for this activity
expires: 5/30/2026
Earn Credit / Learning Objectives & Disclosures:...
Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.